Linda F Thompson Selected Research

5'-Nucleotidase (5' Nucleotidase)

1/2016	Extracellular Adenosine Production by ecto-5'-Nucleotidase (CD73) Enhances Radiation-Induced Lung Fibrosis.
5/2012	Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease.
10/2011	Ecto-5'-nucleotidase (CD73) decreases mortality and organ injury in sepsis.
3/2010	CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.
3/2007	Cardioprotection by ecto-5'-nucleotidase (CD73) and A2B adenosine receptors.
3/2007	Protective role of ecto-5'-nucleotidase (CD73) in renal ischemia.
4/2006	Ecto-5'-nucleotidase (CD73)-mediated adenosine production is tissue protective in a model of bleomycin-induced lung injury.
12/2004	Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism.
12/2004	Crucial role for ecto-5'-nucleotidase (CD73) in vascular leakage during hypoxia.
10/2002	Ecto-5'-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Linda F Thompson Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 02/2005
6	Inflammation (Inflammations) 05/2012 - 01/2004
5	Hypoxia (Hypoxemia) 02/2008 - 10/2002
3	Fibrosis (Cirrhosis) 01/2017 - 04/2006
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2014 - 10/2009
3	Human Influenza (Influenza) 12/2011 - 08/2011
2	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2005
2	Pneumonia (Pneumonitis) 01/2017 - 04/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2013 - 05/2012
2	Lung Injury 10/2011 - 04/2006
2	Severe combined immunodeficiency due to adenosine deaminase deficiency 06/2008 - 08/2002
1	Corneal Injuries 07/2020
1	Brain Neoplasms (Brain Tumor) 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 01/2019
1	Neoplasm Metastasis (Metastasis) 01/2014
1	Hematologic Neoplasms (Hematological Malignancy) 01/2013
1	Sepsis (Septicemia) 10/2011
1	Infections 10/2011
1	Acute Lung Injury 01/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2008
1	Multiple Sclerosis 07/2008
1	Infarction (Infarctions) 03/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2007
1	Ischemia 03/2007

Drug/Important Bio-Agent (IBA)

16	Adenosine (Adenocard)FDA LinkGeneric 01/2019 - 12/2004
10	5'-Nucleotidase (5' Nucleotidase)IBA 01/2016 - 10/2002
6	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2019 - 01/2004
4	Adenosine Triphosphate (ATP)IBA 05/2012 - 10/2002
3	Adenosine Monophosphate (AMP)IBA 03/2010 - 10/2002
3	Oxygen (Dioxygen)IBA 02/2008 - 10/2002
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2006
2	Adenosine DeaminaseIBA 01/2016 - 09/2006
2	AntibodiesIBA 01/2016 - 10/2009
2	CytokinesIBA 07/2014 - 10/2011
2	Adenine NucleotidesIBA 12/2004 - 10/2002
2	Adenosine Diphosphate (ADP)IBA 12/2004 - 10/2002
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Annexin A5IBA 01/2021
1	Carbon Nanotubes (Carbon Nanotube)IBA 01/2021
1	SS-A antibodiesIBA 07/2020
1	EnzymesIBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2014
1	Purinergic P1 Receptor AntagonistsIBA 01/2014
1	B-Cell Activating FactorIBA 12/2011
1	InterferonsIBA 12/2011
1	AutoantibodiesIBA 12/2011
1	hydroxide ionIBA 12/2011
1	25-hydroxyvitamin DIBA 12/2011
1	Peroxidase (Myeloperoxidase)IBA 10/2011
1	Subunit VaccinesIBA 10/2011
1	Neuraminidase (Sialidase)IBA 10/2011
1	VaccinesIBA 10/2011
1	Prednisone (Sone)FDA LinkGeneric 08/2011
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 01/2011
1	AllergensIBA 01/2011
1	EndotoxinsIBA 01/2011
1	Viral ProteinsIBA 10/2009
1	Surface Antigens (Surface Antigen)IBA 10/2009
1	deoxyribonucleoside kinasesIBA 06/2008
1	Small Interfering RNA (siRNA)IBA 02/2008
1	acetamideIBA 02/2008
1	1-propyl-8-(4-sulfophenyl)xanthineIBA 02/2008
1	CarrageenanIBA 05/2007
1	Messenger RNA (mRNA)IBA 09/2006
1	Pentostatin (Nipent)FDA LinkGeneric 09/2006
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2006
1	indium-bleomycinIBA 04/2006
1	nucleotidaseIBA 04/2006
1	Biological ProductsIBA 02/2005
1	ORALIT (ORS)IBA 02/2005
1	NucleotidesIBA 12/2004
1	Purinergic P1 Receptor AgonistsIBA 12/2004
1	4-O-carboxymethylascochlorinIBA 10/2002
1	LuciferasesIBA 10/2002
1	Antisense OligonucleotidesIBA 10/2002
1	alpha,beta-methyleneadenosine 5'-diphosphateIBA 10/2002
1	Cytochromes c (Cytochrome c)IBA 08/2002

Therapy/Procedure

4	Therapeutics 01/2019 - 03/2007
2	Immunotherapy 06/2011 - 03/2010
1	Photothermal Therapy 01/2021
1	Radiotherapy 01/2017
1	Stem Cell Transplantation 01/2013
1	Ligation 10/2011
1	Punctures 10/2011
1	Subcutaneous Injections 05/2007